RITM.PR.B sets a $0.6103 payout for Q3, yielding 9.71% based on current share price. Rithm Capital Corp. has declared a quarterly dividend of $0.6103 per share for its 7.125% Series B Preferred Stock (RITM.PR.B). The dividend reflects a forward yield of 9.71%, based on the
RITM.PR.C announces a $0.5674 per share dividend, yielding 9.26%, payable to shareholders of record July 31. Rithm Capital Corp. has declared a quarterly dividend of $0.5674 per share for its 6.375% Preferred Series C (RITM.PR.C). The dividend offers a forward yield of 9.2
The fund returned 4.18% in Q1 2026, beating Russell 2000 Growth and hedge fund indices amid market volatility. GROW Small Cap Equity Long/Short Fund reported a 4.18% return in Q1 2026, surpassing the Russell 2000 Growth Index’s -2.80% and the HFRI Equity Hedge Index’s -0.2
GROW Small Cap Equity Long/Short Fund returned 4.18% in Q1 2026, beating key indexes amid geopolitical volatility and Palantir exposure. GROW Small Cap Equity Long/Short Fund reported a 4.18% return in Q1 2026, surpassing the Russell 2000 Growth Index’s -2.80% and HFRI Equ
LM Funding targets AI co-location revenue of up to $50 million annually by repurposing 26 megawatts of power capacity for GPU workloads. LM Funding America Inc (NASDAQ:LMFA) is pivoting its Bitcoin mining infrastructure toward high-performance computing and AI, purchasing
U.S. stock futures decline after megacap tech losses push Nasdaq and S&P 500 lower amid AI spending concerns and geopolitical risks. U.S. stock futures traded lower Tuesday following a mixed session on Monday, with the Nasdaq and S&P 500 dragged down by a sharp sell-off in
Executive Vice President sells 14,299 shares for $404,000 Dennis DeLoye, Executive Vice President at Associated Banc-Corp, sold 14,299 shares on May 26, 2026, for $404,000. The transaction was a derivative transaction where non-qualified stock options were exercised a
Georg Schubiger will replace Giorgio Pradelli as president of the Association of Swiss Asset and Wealth Management Banks in September 2026. Georg Schubiger, co-CEO of Vontobel, will take over as president of the Association of Swiss Asset and Wealth Management Banks (VAV)
Wall Street analysts highlight three Nasdaq-listed biotech firms as potential takeover targets following AbbVie’s $6.9B Apogee deal. AbbVie’s pending $6.9 billion acquisition of Apogee Therapeutics has reignited biotech merger speculation, focusing attention on firms with
The acquisition, set to close in Q3 2026, will be funded from existing cash reserves and is expected to boost earnings immediately. Bristow Group (VTOL) will acquire Berry Aviation from Acorn Capital Management for $105M in cash. The transaction is slated to close in Q3 20
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.